Cladribine
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Cladribine and local guidelines before prescribing.
Mechanism
Purine analogue depleting lymphocytes.
Uses
Relapsing multiple sclerosis (oral), hairy cell leukaemia.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Lymphopenia, infections (herpes zoster), headache, malignancy risk.
Interactions
Immunosuppressants; live vaccines contraindicated.
Contraindications and cautions
Active infection, pregnancy, HIV
Monitoring
Lymphocytes, LFT
Pregnancy and breastfeeding
Contraindicated; contraception during and 6 months after
Renal and hepatic impairment
Avoid in moderate to severe renal impairment
Overdose and reversal
Supportive
Special advice
Check lymphocyte count and exclude infection and pregnancy before each course.
More from the textbook: uses, cautions and other points
- Avoid teriflunomide (washout needed), fingolimod and other S1P modulators (stop 2 months before, with rebound risk), cladribine, alemtuzumab (wait 4 months) and mitoxantrone.
Neurology: Multiple Sclerosis and inflammatory disease - MS relapses fall in pregnancy and rise after delivery; avoid teriflunomide, S1P modulators and cladribine.
Neurology: Multiple Sclerosis and inflammatory disease - Purine analogues (fludarabine, cladribine) and bendamustine - profound immunosuppression - irradiated blood for life , PCP prophylaxis.
Haematology: Anatomy Physiology and Pharmacology - Cladribine | Oral, short courses | Lymphopenia, infections (shingles), teratogenic
Neurology: Anatomy, Physiology and Pharmacology - Cladribine (tablets) - two short courses a year apart ("immune reconstitution").
Neurology: Multiple Sclerosis and inflammatory disease - Cladribine: Low lymphocytes; shingles; teratogenic - contraception for 6 months after each course.
Neurology: Multiple Sclerosis and inflammatory disease - Cladribine | Oral courses; lymphopenia, shingles; contraception 6 months after.
Neurology: Multiple Sclerosis and inflammatory disease - Start DMTs early; high-efficacy options include anti-CD20 drugs, natalizumab, S1P modulators, cladribine and alemtuzumab.
Neurology: Multiple Sclerosis and inflammatory disease
Where it is discussed in the book
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Multiple Sclerosis and inflammatory disease (6 mentions)
- Haematology: Anatomy Physiology and Pharmacology (3 mentions)
- Haematology: Leukaemias, myeloproliferative neoplasms and myelodysplasia (2 mentions)
- Haematology: Haemoglobinopathies and Transfusion (1 mention)
- ID: Hospital infection, the immunocompromised host, vaccination and public health (1 mention)
- Clinical Immunology: Biologics, immunotherapy, checkpoint toxicity and transplant immunology (1 mention)